Orphenadrine Citrate

Prescription

商品名： ORPHENADRINE CITRATE

剤形

Tablet

投与経路

ORAL

製造会社

Northwind Health Company, LLC

About This Medication

DESCRIPTION Orphenadrine citrate is the citrate salt of orphenadrine. It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol. The chemical name of orphenadrine citrate is (±) -N,N -Dimethyl-2-[( o -methyl-α-phenylbenzyl)oxy]ethylamine citrate (1:1) having molecular formula C 18 H 23 NO•C 6 H 8 O 7 and molecular weight of 461.51. It has the following structural formula: Each tablet for oral administration contains 100 mg orphenadrine citrate. Each Orphenadrine citrate extended- release tablet contains the following inactive ingredients: hydroxypropyl methylcellulose, lactose monohydrate and magnesium stearate. Image

有効成分

成分	含有量
Orphenadrine Citrate	-

適応症と用法

INDICATIONS AND USAGE Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.

用量と投与方法

DOSAGE AND ADMINISTRATION Adults Two tablets per day; one in the morning and one in the evening.

Side Effects Overview

ADVERSE REACTIONS Adverse reactions of orphenadrine are mainly due to the mild anticholinergic action of orphenadrine, and are usually associated with higher dosage. Dryness of the mouth is usually the first adverse effect to appear. When the daily dose is increased, possible adverse effects include: tachycardia, palpitation, urinary hesitancy or retention, blurred vision, dilatation of pupils, increased ocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, hypersensitivity reactions, pruritus, hallucinations, agitation, tremor, gastric irritation, and rarely urticaria and other dermatoses. Infrequently, an elderly patient may experience some degree of mental confusion. These adverse reactions can usually be eliminated by reduction in dosage. Very rare cases of aplastic anemia associated with the use of orphenadrine tablets have been reported. No causal relationship has been established.

警告と注意事項

WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

禁忌

CONTRAINDICATIONS Orphenadrine citrate extended-release tablets are contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (mega-esophagus) and myasthenia gravis. Orphenadrine citrate tablets are contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

SVG · Badge · Embed

DrugFYI

詳しい薬理学・作用機序のデータをお探しですか？

Orphenadrine Citrate DrugFYI で

外部リソース

同一有効成分

Orphenadrine Citrate, Aspirin And Caffeine Galt Pharmaceuticals, LLC

出典： openfda

最終更新： 2026-03-19

Frequently Asked Questions

INDICATIONS AND USAGE Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.

DOSAGE AND ADMINISTRATION Adults Two tablets per day; one in the morning and one in the evening.

WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

CONTRAINDICATIONS Orphenadrine citrate extended-release tablets are contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (mega-esophagus) and myasthenia gravis. Orphenadrine citrate tablets are contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

Orphenadrine Citrate is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

Similar Tablet Products

Cough Drops Black Cherry …

Magnesium Oxide

Arum Maculatum Root

Arsenic Trioxide - Histamine …

Azathioprine

Pioglitazone And Metformin Hydrochloride

Browse all Tablet products →

References & Data Sources

• DailyMed — Orphenadrine Citrate drug label (National Library of Medicine)
• openFDA — Orphenadrine Citrate label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 994521 (NLM Normalized Drug Names)
• NDC Directory — Orphenadrine Citrate (FDA National Drug Code)

医療免責事項

このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。

疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。

データソース： DailyMed (NLM), openFDA, MFDS